Jackson Thornton Asset Management, LLC Biomarin Pharmaceutical Inc Transaction History
Jackson Thornton Asset Management, LLC
- $971 Million
- Q3 2025
A detailed history of Jackson Thornton Asset Management, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Jackson Thornton Asset Management, LLC holds 7,092 shares of BMRN stock, worth $388,145. This represents 0.04% of its overall portfolio holdings.
Number of Shares
7,092
Previous 4,989
42.15%
Holding current value
$388,145
Previous $274,000
40.15%
% of portfolio
0.04%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding BMRN
# of Institutions
669Shares Held
182MCall Options Held
1.52MPut Options Held
1.01M-
Black Rock Inc. New York, NY22.7MShares$1.24 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.6MShares$1.02 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.2MShares$833 Million0.65% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$804 Million0.46% of portfolio
-
State Street Corp Boston, MA8.76MShares$480 Million0.02% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...